Riskpilot← Back to searchSign inGet full accessSOGN DYREKLINIKK AS
ASActiveOrg 917825432Ofta Vest 15, 6887 LærdalVeterinary activities · NACE 7500Est. 20165 employees
Revenue 2025
NOK 3,6M
+3% vs 2024
EBITDA margin
9.3%
+40% vs 2024
Equity ratio
-57.5%
Financial strength
Net profit 2025
NOK 24K
+111% vs 2024
| Revenue | NOK 3,6M | +3% |
| EBITDA | NOK 339K | +40% |
| Net profit | NOK 24K | +111% |
| Total assets | NOK 1,3M | +6% |
| Equity | NOK -725K | +3% |
| Employees | 5 | — |
Legal name
SOGN DYREKLINIKK AS
Org number
917825432
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
24. oktober 2016
Share capital
NOK 350 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Drive veterinærtjenester og det som høyrer inn under dette. Selskapet kan delta som aksjonær eller på annen måte ved investering i andre verksemder.
Address
Ofta Vest 15, 6887 Lærdal
Phone
+4757112040
Email
sogndyreklinikk@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 935 | 4 384 | 4 273 | 3 509 | 3 629 |
| Staff expenses | −1 839 | −1 956 | −1 522 | −1 107 | −1 279 |
| EBITDA | −41 | 197 | 459 | 242 | 339 |
| Depreciation & amort. | −254 | −357 | −360 | −319 | −198 |
| EBIT | −294 | −159 | 98 | −77 | 141 |
| Net financials | −68 | −103 | −118 | −133 | −117 |
| Profit before tax | −362 | −262 | −19 | −211 | 24 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −362 | −262 | −19 | −211 | 24 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 847 | 1 837 | 1 555 | 1 191 | 1 261 |
| Equity | −727 | −989 | −538 | −749 | −725 |
| Long-term debt | 1 969 | 1 832 | 1 513 | 1 344 | 1 119 |
| Short-term debt | 605 | 994 | 581 | 596 | 867 |
| Total debt | 2 574 | 2 826 | 2 093 | 1 940 | 1 987 |
EBITDA margin
9.3%
This company
15.8%
Market median
-41% vs market
20212025
Equity ratio
-57.5%
This company
38.2%
Market median
-251% vs market
20212025
Return on equity
2368000.0%
This company
18.4%
Market median
+12869465% vs market
20212025
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
20212025
Asset turnover
2.88×
This company
1.12×
Market median
+157% vs market
20212025
Debt / equity
2.74×
This company
0.62×
Market median
-342% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 14.29% | 14.29% | 2023 | |
| Individual | 14.29% | 14.29% | 2023 | |
| Individual | 7.14% | 7.14% | 2023 | |
| Individual | 3.57% | 3.57% | 2023 | |
| Individual | 3.57% | 3.57% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SOGN DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingjerd Leirstein Bøkenes | Chairman | 0 companies |